IRE: 20–35% CR in immunocompetent mice; 0% CR in immunodeficient mice. Generated tumor antigen-specific T cell responses.IRE + TLR7/anti-PD-1 were not superior to IRE alone in survival and tumor growth reduction. Here, TLR7 is linked to neoplasm.